⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18872219 | 1.00 | — | — | |
| SCHEMBL18784079 | 1.00 | — | — | |
| SCHEMBL13390519 | 1.00 | — | — | |
| SCHEMBL23912229 | 0.91 | — | — | |
| SCHEMBL21010661 | 0.90 | — | — | |
| SCHEMBL17772385 | 0.78 | — | — | |
| SCHEMBL15133755 | 0.78 | INPP5A (0.30) | — | |
| SCHEMBL13478090 | 0.76 | — | — | |
| SCHEMBL13980885 | 0.76 | — | — | |
| SCHEMBL10013336 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107635558-A | Bu Luomo domain inhibitor | 赛尔基因昆蒂赛尔研究公司 | 2018-01-26 | — | — | CN | disclosed |
| EP-3222293-A1 | OLIGOMER-OPIOID AGONIST CONJUGATES | Nektar Therapeutics (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-2651915-B1 | CONTINUOUS ARYCYCLIC COMPOUND | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-25 | — | — | EP | disclosed |
| US-20110283419-A1 | Regulation of Cotton Fiber Growth by Extracellular Nucleotides and Ectoapyrases | BOARD OR REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-11-17 | — | — | US | disclosed |
| EP-1187240-B1 | OPERATION METHOD FOR POLYMER ELECTROLYTIC FUEL CELL | PANASONIC CORP (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-20070087425-A1 | Using modified saccharomyces as bioreactors for fermentation of farnesol, nerolidol and/or geranylgeraniol | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2007-04-19 | — | — | US | disclosed |
| WO-2007041112-A2 | DIHYDRO-[1H]-QUINOLIN-2-ONE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-04-12 | — | — | WO | disclosed |